In 2025, sales are anticipated to grow by a mid-to-high single-digit percentage at CER 5. Sanofi confirms the expectation of a strong rebound in business EPS with growth at a low double-digit ...

The approval allows Imfinzi to be used in... Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing The U.S. Food and Drug Administration (FDA) has approved ...

Hemophilia significantly impacts lives beyond bleeding episodes, causing absenteeism, pain, and disability. India, with the second-highest hemophilia population, faces challenges in diagnosis and ...

World Hemophilia Day is observed on April 17. It raises awareness about bleeding disorders. Hemophilia is a genetic condition causing prolonged bleeding. Early diagnosis and treatment are crucial.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ...

What is hemophilia? Every parent wants their child to grow up in a healthy manner and meet their developmental goals. But sometimes, some kids sustain severe wounds from minor bumps or falls ...

This World Hemophilia Day, let’s understand more about this condition and how it can be prevented from Dr Gagan Saini, Vice Chairman- Radiation Oncology at Yashoda Medicity. “Hemophilia is a ...

Did you know that healing the mind can help heal the body too, even when managing chronic conditions like hemophilia? While modern medicine works to treat the physical symptoms, many overlook the ...

For some children, these everyday signs might be early warnings of hemophilia, a rare but serious blood disorder. In its early stages, hemophilia can be incredibly easy to overlook, which is why ...

Eligible patients taking Camzyos in the maintenance phase now only require twice-yearly echocardiogram monitoring. The Food and Drug Administration (FDA) has updated the labeling for Camzyos ...

The findings, which support the potential of this gene therapy as a safe and effective long-term solution for hemophilia B, were published today in the New England Journal of Medicine. Hemophilia ...